Skip to main content
Premium Trial:

Request an Annual Quote

InforMax Names Lee Hood Chairman of Advisory Board

NEW YORK, Nov 2 – InforMax said Thursday it has appointed Leroy Hood chairman of its scientific advisory board.

" Lee's track record in biotechnology, and his many scientific and technological accomplishments, are well-known," Alex Titomirov, president and CEO of InforMax, said in a statement.

" We are very pleased that he has agreed to chair the InforMax Scientific Advisory Board and look forward to benefiting from his insights and experience in the years ahead,” Titomirov added.

Hood is considered a leader in the move to apply computer technology to scientific research.

Last year Hood founded the Institute for Systems Biology in Seattle, which will focus on advancing biology as an information science.   He has an M.D. from Johns Hopkins University and a Ph.D. in biochemistry from the California Institute of Technology.

He is also a scientific advisor to other companies, including Lynx, Illumina, Immunex, People Genetics, Orchid BioSciences, and RealTime Health, a dotcom for predictive medicine that is chaired by InforMax’s CEO.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.